Infectious Diseases

Biotech firm Novavax submits COVID-19 vaccine for approval by Health Canada

The regulatory filings include clinical data from a trial of 30,000 participants in the U.S. and Mexico, which found 100% protection against moderate and severe disease and 90.4% efficacy overall, Novavax said.
Regular TB screening cost effective way to prevent spread in vulnerable areas: study
QUIZ: What do you know about Staphylococcal infections?

Staphylococcal infections are common in community and hospital settings, and rise among seniors during fall and winter. They are usually caused by Staphylococcus aureus and increasingly methicillin-resistant S. aureus (MRSA). Test your knowledge of S. aureus.
U.S. FDA paves way for Pfizer COVID-19 vaccinations in young kids
NACI names several more groups who should qualify for COVID-19 booster shots
Third dose COVID-19 vaccination plan coming 'for all Ontarians' next week: Elliott
Manitoba extends third dose vaccine coverage, sees wide public sector uptake

The province is now recommending booster shots for residents of seniors homes and other congregate living centres for the elderly.
POP QUIZ: Post-acute COVID-19 syndrome

Post-acute COVID-19 syndrome describes patients that have lingering symptoms (e.g., 12 weeks or longer) after the start of acute COVID‑19.

Scientists hope to link lab bench with pharmacy shelves through Edmonton drug plant